A retrospective, real world study of intention to treat analysis Tisgenlecleucel therapy for pediatric and young adult acute lymphoblastic leukemia
Latest Information Update: 12 Jan 2021
At a glance
- Drugs Tisagenlecleucel (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology